Stage IV Adrenocortical Carcinoma Active Not Recruiting Phase 3 Trials for Filgrastim (DB00099)

IndicationStatusPhase
DBCOND0028759 (Stage IV Adrenocortical Carcinoma)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00304070Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical TumorTreatment